Cell-matrix interactions in chronic lung disease

J. Burgess (Groningen, Netherlands)

Source: Virtual Congress 2021 – Repair and regeneration in chronic lung disease and lung cancer
Session: Repair and regeneration in chronic lung disease and lung cancer
Session type: Symposium
Number: 109

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Burgess (Groningen, Netherlands). Cell-matrix interactions in chronic lung disease. Virtual Congress 2021 – Repair and regeneration in chronic lung disease and lung cancer

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cellular interactions in the pathogenesis of interstitial lung diseases
Source: Eur Respir Rev 2015; 24: 102-114
Year: 2015



What are gene-environment interactions and how do they underlie lung disease?
Source: International Congress 2015 – PG15 Gene-environment interactions in lung disease
Year: 2015




Dissecting chronic lung disease
Source: ERS Lung Science Conference 2017
Year: 2017

Senotherapies for chronic lung disease
Source: ERS Lung Science Conference 2020
Year: 2020


The link between inflammation and lung cancer: lessons from chronic obstructive pulmonary disease
Source: International Congress 2018 – Scientific Year in Review
Year: 2018


Drug-drug interactions in hospitalized patients with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs
Year: 2012

Host–microbe cross-talk in the lung microenvironment: implications for understanding and treating chronic lung disease
Source: Eur Respir J, 56 (2) 1902320; 10.1183/13993003.02320-2019
Year: 2020



Host-microbe interactions in lung transplantation
Source: International Congress 2015 – Microbial impacts at different human ages
Year: 2015



Systemic inflammation: a link between chronic obstructive pulmonary disease and lung cancer?
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009


Interplay between bacterial infections, hypoxia and the development of chronic lung diseases
Source: Annual Congress 2009 - Mechanisms of infection: what's new?
Year: 2009


Inflammatory cell microlocalisation and airway dysfunction: cause and effect?
Source: Eur Respir J 2007; 30: 1043-1056
Year: 2007



Investigation of relationships between inflammation and brain disease in COPD
Source: International Congress 2018 – Evaluation of COPD and various diseases by different imaging modalities
Year: 2018




Prediction of chronic lung disease
Source: Eur Respir J 2003; 22: Suppl. 45, 139s
Year: 2003

Endothelial interactions of neutrophils under flow in chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 25: 612-617
Year: 2005



Prevalence and trafficking of circulating fibrocytes in smoking-related fibrogenic lung diseases
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015

Role of low-grade inflammation markers and soluble cell adhesion molecules in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008


Circulating adhesion molecules in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 316s
Year: 2004

Maintenance of disease chronicity by dysregulated macrophage-epithelial cell interactions
Source: ERS Research Seminar 2016
Year: 2016